These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20884817)

  • 21. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How to measure the structures, or new stereology. II. Methods of stereological estimation of the absolute dimensions of cell structures in light microscopy].
    Beznusenko GV; Sesorova IS; Mironov AA; Banin VV
    Morfologiia; 2005; 128(6):63-6. PubMed ID: 16755794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design-based stereology in neuroscience.
    Schmitz C; Hof PR
    Neuroscience; 2005; 130(4):813-31. PubMed ID: 15652981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient quantification of afferent cochlear ultrastructure using design-based stereology.
    Francis HW; Rivas A; Lehar M; Saito Y; Mouton PR; Ryugo DK
    J Neurosci Methods; 2006 Jan; 150(2):150-8. PubMed ID: 16115689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing.
    Weingand K; Brown G; Hall R; Davies D; Gossett K; Neptun D; Waner T; Matsuzawa T; Salemink P; Froelke W; Provost JP; Dal Negro G; Batchelor J; Nomura M; Groetsch H; Boink A; Kimball J; Woodman D; York M; Fabianson-Johnson E; Lupart M; Melloni E
    Fundam Appl Toxicol; 1996 Feb; 29(2):198-201. PubMed ID: 8742316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two platelet count estimation methodologies for peripheral blood smears.
    Malok M; Titchener EH; Bridgers C; Lee BY; Bamberg R
    Clin Lab Sci; 2007; 20(3):154-60. PubMed ID: 17691671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory compliance for point-of-care testing: 2009 United States perspective.
    Ehrmeyer SS; Laessig RH
    Clin Lab Med; 2009 Sep; 29(3):463-78. PubMed ID: 19840680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proposed testing framework for developmental immunotoxicology (DIT).
    Holsapple MP; Burns-Naas LA; Hastings KL; Ladics GS; Lavin AL; Makris SL; Yang Y; Luster MI
    Toxicol Sci; 2005 Jan; 83(1):18-24. PubMed ID: 15456913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of emerging technologies in toxicology and safety assessment.
    Reynolds VL
    Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer assisted data collection for stereology: rationale and description of point counting stereology (PCS) software.
    Pentcheff ND; Bolender RP
    Microsc Res Tech; 1992 Jun; 21(4):347-54. PubMed ID: 1638053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External quality assessment of sputum smear microscopy: a matter of careful technique and organisation.
    Van Deun A
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):507-8. PubMed ID: 12797690
    [No Abstract]   [Full Text] [Related]  

  • 34. Design-based stereology: Planning, volumetry and sampling are crucial steps for a successful study.
    Tschanz S; Schneider JP; Knudsen L
    Ann Anat; 2014 Jan; 196(1):3-11. PubMed ID: 23769130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nonclinical fertility study design for pharmaceuticals.
    Lerman SA; Hew KW; Stewart J; Stump DG; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):429-36. PubMed ID: 20025039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benchmark dose approaches in chemical health risk assessment in relation to number and distress of laboratory animals.
    Oberg M
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):451-4. PubMed ID: 20800084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process.
    Sailstad DM; Hattan D; Hill RN; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):249-57. PubMed ID: 11754529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
    Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
    Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How much is there really? Why stereology is essential in lung morphometry.
    Weibel ER; Hsia CC; Ochs M
    J Appl Physiol (1985); 2007 Jan; 102(1):459-67. PubMed ID: 16973815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.